Ixekizumab Diabetes Intervention Trial (I-DIT)

NCT04589325 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

127

Enrollment

OTHER

Sponsor class

Conditions

Type1 Diabetes Mellitus

Interventions

DRUG: Ixekizumab
DRUG: Placebo

Sponsor

Göteborg University